These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5827348)

  • 41. Structural and histochemical features of cortical thymic epithelial cells in mice with chemically-induced lymphoid leukemia.
    Valkov I; Marinova T; Davidorff M; Takács L
    Thymus; 1988; 12(1):39-50. PubMed ID: 3245059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells.
    Erikson JM; Tweedie DJ; Ducore JM; Prough RA
    Cancer Res; 1989 Jan; 49(1):127-33. PubMed ID: 2908840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F; Ueda K; Kawashima K; Jamshedur Rahman SM; Isobe K; Yoshida T; Hasegawa Y; Ando K; Iwamoto T; Nagura E
    J Immunol; 1987 Apr; 138(7):2359-65. PubMed ID: 2951438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Zwelling LA; Michaels S; Schwartz H; Dobson PP; Kohn KW
    Cancer Res; 1981 Feb; 41(2):640-9. PubMed ID: 7192601
    [No Abstract]   [Full Text] [Related]  

  • 45. Resting cells in L1210 and JB-1 ascites tumors with special emphasis on recycling.
    Hartmann NR; Dombernowsky P; Bichel P
    Cancer Treat Rep; 1976 Dec; 60(12):1861-70. PubMed ID: 1026340
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis].
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Bull Cancer; 1996 May; 83(5):371-8. PubMed ID: 8680089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.
    Somerville L; Cory AH; Cory JG
    In Vivo; 2002; 16(3):175-7. PubMed ID: 12182112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxicity of cinnamic aldehyde on leukemia L1210 cells.
    Moon KH; Pack MY
    Drug Chem Toxicol; 1983; 6(6):521-35. PubMed ID: 6653439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokinetic analysis of L1210 leukemia after continuous infusion of hydroxyurea in vivo.
    Moran RE; Straus MJ
    Cancer Res; 1979 May; 39(5):1616-22. PubMed ID: 427801
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
    Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
    Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
    Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
    Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of transplantable murine "L-1210" leukemia growth with hemi-and allogeneic immunocytes.
    Schneiberg K; Rytwiński K; Bartnikowa W
    Pol Med Sci Hist Bull (1973); 1973; 15(6):597-604. PubMed ID: 4134227
    [No Abstract]   [Full Text] [Related]  

  • 53. [The role of N-nitrosourea-induced changes in the nucleoid structure and activity of repair enzymes in the development of drug resistance in mice with leukemia L1210].
    Durdyeva ED; Ponomarenko NA; Kukushkina GV; Gorbacheva LB
    Biokhimiia; 1987 Aug; 52(8):1335-43. PubMed ID: 3663767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
    Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
    Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The specific cytotoxic effect of DBA2 mouse DNA on L1210 leukemia.
    Glick JL; Salim AP; Crystal HA
    Life Sci; 1968 Oct; 7(20):1075-81. PubMed ID: 5712278
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
    Mitchell MS; Mokyr MB; Goldwater DJ
    Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ultrastructure of mouse metaphase chromosomes.
    Michalska J; Chorazy M
    Acta Med Pol; 1979; 20(4):339-46. PubMed ID: 397727
    [No Abstract]   [Full Text] [Related]  

  • 58. The mechanism of inhibition of DNA synthesis by HH07A, a derivative of hainanensine.
    Ye Y; Xu C
    Chin Med Sci J; 1997 Sep; 12(3):139-42. PubMed ID: 11360622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.
    Mattern MR; Mong SM; Bartus HF; Mirabelli CK; Crooke ST; Johnson RK
    Cancer Res; 1987 Apr; 47(7):1793-8. PubMed ID: 3028614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of neocarzinostatin on DNA synthesis in L1210 cells.
    Sawada H; Tatsumi K; Sasada M; Shirakawa S; Nakamura T
    Cancer Res; 1974 Dec; 34(12):3341-6. PubMed ID: 4473265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.